Together, these data demonstrate that Elovl4 is not only essential for tumor suppression, but also sufficient to reduce SCC development in Ripk4-deficient, Pik3caH1047R-mutant skin (Figure 4F). The gene discussed is RIPK4; the disease is neoplasm.